Search Results 161-170 of 16099 for pharmacogenetics
The purpose of this study is to investigate the facilitators and barriers of adults with a history of cocaine use disorder (CocUD) in sustained remission to ...
The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.
About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...
Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...
But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment ...
The purpose of this study is perform HOUSES index analysis on 500 patients with a first-degree relative diagnosed with pancreatic cancer to see if there is a ...
When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions. Now, add to that ...
View faculty and staff of the Pharmacogenomics and Drug Targets Lab led by Liewei Wang, M.D., Ph.D.
About this study. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients ...
This study is designed to explore the experiences of individuals growing up with a genetic diagnosis of SCAs and their families. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.